BMRN Market Cap & Key Metrics
BioMarin Pharmaceutical Inc.
$57.30
+$2.16(+3.92%)
48
Overall
65
Value
27
Tech
52
Quality
Market Cap
$10.67B
Volume
216.80K
52W Range
$49.26 - $70.98
Target Price
$90.77
BMRN market cap is $10.67B. This page lists BioMarin Pharmaceutical Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
BMRN Key Metrics
- Market cap
- $10.67B
- P/E ratio (current-year EPS estimate)
- 13.98
- EPS estimate, current year
- $4.10
- EPS growth, 3-year
- +33.79%
- Value score
- 65
- Quality score
- 52
- Technical score
- 27
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.22B | $2.85B | $2.42B | $2.10B | $1.85B |
| EBITDA | $575.56M | $654.21M | $314.47M | $271.04M | $47.43M |
| EPS | $1.82 | $2.25 | $0.89 | $0.76 | $-0.35 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMRN | $57.30 | +3.9% | 216.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioMarin Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW